Get the Stockscreener App
3.52
11.04%
0.35
Adverum Biotechnologies Inc stock is traded at $3.52, with a volume of 172.42K.
It is up +11.04% in the last 24 hours and up +39.68% over the past month.
Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.
See More
Previous Close:
$3.17
Open:
$3.22
24h Volume:
172.42K
Relative Volume:
0.97
Market Cap:
$73.86M
Revenue:
-
Net Income/Loss:
$-94.11M
P/E Ratio:
-0.5857
EPS:
-6.01
Net Cash Flow:
$-86.06M
1W Performance:
+14.29%
1M Performance:
+39.68%
6M Performance:
-20.00%
1Y Performance:
-48.39%
1-Day Range:
$3.18
$3.57
1-Week Range:
$2.9297
$3.57
52-Week Range:
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Name
Adverum Biotechnologies Inc
Sector
Industry
Phone
(650) 649-1004
Address
100 CARDINAL WAY, REDWOOD CITY, CA
Compare ADVM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
3.52 | 66.52M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-25-24 | Initiated | Oppenheimer | Outperform |
| Apr-30-24 | Initiated | H.C. Wainwright | Buy |
| Jul-07-22 | Upgrade | Truist | Hold → Buy |
| Jul-23-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-03-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-29-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Apr-29-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-29-21 | Downgrade | Truist | Buy → Hold |
| Dec-16-20 | Initiated | UBS | Neutral |
| Nov-12-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jun-26-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| May-13-20 | Initiated | RBC Capital Mkts | Outperform |
| May-05-20 | Upgrade | SunTrust | Hold → Buy |
| Apr-28-20 | Initiated | Goldman | Buy |
| Mar-16-20 | Initiated | SVB Leerink | Outperform |
| Feb-10-20 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-10-20 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Oct-15-19 | Reiterated | Chardan Capital Markets | Neutral |
| Sep-13-19 | Reiterated | Chardan Capital Markets | Neutral |
| Jun-14-19 | Resumed | Raymond James | Mkt Perform |
| Nov-02-18 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-02-18 | Downgrade | SunTrust | Buy → Hold |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-30-18 | Initiated | SunTrust | Buy |
| Feb-15-18 | Resumed | Piper Jaffray | Overweight |
| Oct-12-17 | Initiated | Raymond James | Outperform |
View All
Adverum Biotechnologies Inc Stock (ADVM) Latest News
Real time breakdown of Adverum Biotechnologies Inc. stock performance2025 Retail Activity & Target Return Focused Stock Picks - Newser
Risk adjusted return profile for Adverum Biotechnologies Inc. analyzed2025 Big Picture & High Conviction Buy Zone Picks - Newser
Sentiment analysis tools applied to Adverum Biotechnologies Inc.Quarterly Trade Summary & Fast Gain Swing Alerts - Newser
Key metrics from Adverum Biotechnologies Inc.’s quarterly dataQuarterly Trade Summary & Free Safe Entry Trade Signal Reports - Newser
Historical volatility pattern of Adverum Biotechnologies Inc. visualizedMarket Activity Recap & Weekly Momentum Picks - Newser
Ranking Adverum Biotechnologies Inc. among high performing stocks via toolsDollar Strength & Capital Efficiency Focused Ideas - Newser
How to use a screener to detect Adverum Biotechnologies Inc. breakouts2025 Big Picture & Safe Capital Growth Trade Ideas - Newser
Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
How does Adverum Biotechnologies Inc. compare to its peers2025 Macro Impact & Verified Trade Idea Suggestions - خودرو بانک
Adverum Biotechnologies’ Talent Acquisition and Equity Incentive Strategy: A Catalyst for Long-Term Value Creation - AInvest
Decoding Adverum Biotechnologies’ Talent Strategy: How Inducement Grants Under Nasdaq Rule 5635(c)(4) Signal Confidence in Long-Term Growth and Innovation in Ocular Gene Therapy - AInvest
Adverum Biotechnologies announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
16,860 Stock Options at $3.08: Adverum Biotechnologies Awards Inducement Grants to New Hires - Stock Titan
What’s the analyst consensus on Adverum Biotechnologies Inc.Product Launch & Verified Momentum Stock Watchlist - خودرو بانک
Is Adverum Biotechnologies Inc. exposed to political riskWall Street Watch & Technical Buy Zone Confirmations - خودرو بانک
Using Bollinger Bands to evaluate Adverum Biotechnologies Inc.Index Update & Risk Controlled Daily Trade Plans - Newser
What is the dividend yield of Adverum Biotechnologies Inc.Weekly Risk Summary & Free Fast Gain Swing Trade Alerts - خودرو بانک
Will Adverum Biotechnologies Inc. benefit from macro trendsMarket Rally & Long-Term Safe Investment Ideas - Newser
Will Adverum Biotechnologies Inc. rebound enough to break evenPortfolio Gains Summary & Fast Exit Strategy with Risk Control - Newser
Does Adverum Biotechnologies Inc. stock benefit from AI growth2025 Volume Leaders & Safe Entry Point Alerts - خودرو بانک
Will earnings trigger a reversal in Adverum Biotechnologies Inc.Weekly Stock Summary & High Accuracy Investment Entry Signals - Newser
Is Adverum Biotechnologies Inc. forming a bottoming base2025 Bull vs Bear & High Return Trade Opportunity Guides - Newser
What dividend growth rate does Adverum Biotechnologies Inc. offerJuly 2025 Gainers & Reliable Price Action Trade Plans - خودرو بانک
Trading Recap: Is Adverum Biotechnologies Inc. forming a breakout patternEarnings Growth Report & Weekly Breakout Opportunity Watchlist - خودرو بانک
Will Adverum Biotechnologies Inc. benefit from AI trendsPortfolio Gains Summary & Safe Swing Trade Setups - خودرو بانک
Applying Wyckoff theory to Adverum Biotechnologies Inc. stockWeekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
What is the long term forecast for Adverum Biotechnologies Inc. stockWeekly Trend Summary & Precise Swing Trade Alerts - khodrobank.com
Is a relief rally coming for Adverum Biotechnologies Inc. holdersJuly 2025 Big Picture & Free Long-Term Investment Growth Plans - Newser
Is Adverum Biotechnologies Inc. likely to announce a buybackJuly 2025 Closing Moves & Weekly High Conviction Trade Ideas - خودرو بانک
Is Adverum Biotechnologies Inc. showing insider buyingMarket Sentiment Report & Precise Trade Entry Recommendations - خودرو بانک
Is Adverum Biotechnologies Inc. stock bottoming outEarnings Miss & Expert Verified Movement Alerts - Newser
Buybacks Report: Will Adverum Biotechnologies Inc. benefit from current market trendsJuly 2025 Selloffs & Daily Entry Point Trade Alerts - خودرو بانک
Detecting support and resistance levels for Adverum Biotechnologies Inc.Portfolio Risk Summary & Entry and Exit Point Strategies - Newser
How to interpret RSI for Adverum Biotechnologies Inc. stockForecast Cut & Precise Buy Zone Identification - Newser
Adverum Biotechnologies Inc. stock prediction for this week2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - Newser
Heatmap analysis for Adverum Biotechnologies Inc. and competitorsWeekly Stock Report & Risk Controlled Swing Alerts - Newser
Adverum Biotechnologies Inc Stock (ADVM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Adverum Biotechnologies Inc Stock (ADVM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
May 15 '25 |
Sale |
2.00 |
9,126 |
18,252 |
87,488 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 27 '25 |
Buy |
5.19 |
16,593 |
86,089 |
141,800 |
| Leonard Braden Michael | 10% Owner |
Apr 22 '25 |
Buy |
3.00 |
300,000 |
900,000 |
3,057,526 |
| Leonard Braden Michael | 10% Owner |
Apr 23 '25 |
Buy |
2.98 |
50,000 |
148,950 |
191,800 |
| Leonard Braden Michael | 10% Owner |
Mar 31 '25 |
Buy |
4.38 |
19,566 |
85,668 |
2,742,317 |
| Leonard Braden Michael | 10% Owner |
Apr 02 '25 |
Buy |
4.04 |
15,209 |
61,408 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 18 '25 |
Buy |
4.69 |
62,341 |
292,418 |
2,667,161 |
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):